Methods for prognosing the ability of a zearalenone analog compound to treat cancer

Details for Australian Patent Application No. 2008318690 (hide)

Owner Eisai R & D Management Co., Ltd.

Inventors Nomoto, Kenichi; Wang, John (yuan); Agoulnik, Sergei

Agent Davies Collison Cave

Pub. Number AU-A-2008318690

PCT Pub. Number WO2009/058908

Priority 61/000,796 29.10.07 US

Filing date 29 October 2008

Wipo publication date 7 May 2009

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

20 May 2010 PCT application entered the National Phase

  PCT publication WO2009/058908 Priority application(s): WO2009/058908

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008318709-Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate

2008318678-Vascular closure device